Typicality: | 0.678 |
Saliency: | 0.664 |
currently | 22 | temporal |
with metastatic prostate cancer | 21 | other |
with a clinical diagnosis of copd | 13 | other |
trial → enrol → patient | 157 |
trial → enroll → patient | 25 |
trial → enroll → participant | 6 |
negative | neutral | positive |
0.175 | 0.712 | 0.113 |
Raw frequency | 188 |
Normalized frequency | 0.664 |
Modifier score | 0.945 |
Perplexity | 191.069 |